These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Seroepidemiology of alphaherpesviruses]. Hashido M Nihon Rinsho; 2000 Apr; 58(4):828-37. PubMed ID: 10774202 [TBL] [Abstract][Full Text] [Related]
8. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice. Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678 [TBL] [Abstract][Full Text] [Related]
10. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines. Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ J Virol; 2021 May; 95(12):. PubMed ID: 33762414 [TBL] [Abstract][Full Text] [Related]
11. Varicella zoster vaccines and their implications for development of HSV vaccines. Gershon AA Virology; 2013 Jan; 435(1):29-36. PubMed ID: 23217613 [TBL] [Abstract][Full Text] [Related]
12. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Stanfield BA; Kousoulas KG; Fernandez A; Gershburg E Viruses; 2021 Aug; 13(8):. PubMed ID: 34452501 [TBL] [Abstract][Full Text] [Related]
13. Glycoproteins gl and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gl-gE deletion mutant in the natural host. Kruger JM; Sussman MD; Maes RK Virology; 1996 Jun; 220(2):299-308. PubMed ID: 8661381 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis--serodiagnosis of alpha herpesviruses]. Ikoma M; The HT; Welling-Wester S Nihon Rinsho; 2000 Apr; 58(4):851-7. PubMed ID: 10774205 [TBL] [Abstract][Full Text] [Related]
15. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus. Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919 [TBL] [Abstract][Full Text] [Related]
17. Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections. Stanfield B; Kousoulas KG Curr Clin Microbiol Rep; 2015 Sep; 2(3):125-136. PubMed ID: 27114893 [TBL] [Abstract][Full Text] [Related]
18. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10). Aurelian L; Kokuba H; Smith CC Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594 [TBL] [Abstract][Full Text] [Related]